Lorenz Räber: New Insights Into Silent Plaque Ruptures in AMI Patients
Lorenz Räber, Vice President of Swiss Society of Cardiology, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“New publication European Heart Journal
In this study, we phenotyped lesions with silent plaque ruptures (PR) in non infarct related vessels of 336 AMI patients and found.
In larger plaque volume, positive remodeling, and thinner fibrous cap associated with rupture. Biomarkers (eg LDL-C, Lp(a), IFNy, interleukin-6; MMP-12; TNFa, hsCRP) were not correlated with multivessel plaque instability.
50% of plaques healed at 1 YR imaging with OCT.
All patients received high intensity statin therapy (at least), and the majority of healed plaques transformed into a fibrous morphology.
Although not powered for events, no excess in CV outcomes was noted in the PR group.
Great Editorial by Aloke Finn, Renu Virmani, CV Path Institute, Washington
Congratulations to the first author Ryota Kakizaki who spent a successful 3 YR fellowship at the Dep of Cardiology Insel Gruppe and we are proud on his persistence on this project published in the European Heart Journal this week.”
Title: Silent plaque ruptures in non-obstructive lesions of non–infarct-related arteries: a multimodality, serial intracoronary imaging study
Authors: Ryota Kakizaki, Flavio G Biccirè, Sylvain Losdat, Yasushi Ueki, Jonas D Häner, Hiroki Shibutani, Tatsuhiko Otsuka, Sarah Bär, Jacob Lønborg, Ernest Spitzer, George C M Siontis, Anna S Ondracek, Robert-Jan van Geuns, Yu-Jen Wang, Christian M Matter, Juan F Iglesias, David Spirk, Joost Daemen, Gregor Fahrni, Felix Mahfoud, Thomas Engstrøm, Irene M Lang, Konstantinos C Koskinas, Lorenz Räber
Read the Full Article on European Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 14, 2026, 16:10Raffaella Colombatti: Proud to Have Authored the New Lancet Seminar on Sickle Cell Disease
-
Mar 14, 2026, 16:05Simon Senanu: D-Dimer – A Small Fragment with Big Clinical Significance
-
Mar 14, 2026, 15:53Ney Carter: Key Advances in the 2026 ACC/AHA Guideline on the Management of Dyslipidemia
-
Mar 14, 2026, 15:45Nicole Odofin: The First Blood Drive Event at Channel 4
-
Mar 14, 2026, 15:41Michael Makris: Romiplostim Use Allows More Chemotherapy to Be Delivered on Time
-
Mar 14, 2026, 15:40Jecko Thachil: Anticoagulation in Patients With Metabolic-Associated Fatty Liver Disease
-
Mar 14, 2026, 15:11Abdul Mannan: Why Apixaban May Be the Safer Choice for Acute VTE
-
Mar 14, 2026, 15:09Cedric Hermans: New Viewpoint on the Challenges of Coagulation Rebalancing in Hemophilia
-
Mar 14, 2026, 14:59Donate Blood and Be the Reason Someone Survives – Damu Sasa